home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Phase III Clinical Trials

 
  March 06, 2012  
     
 
CHI, Philadelphia, PA
March 12-13, 2012


Phase III success rates for the pharmaceutical industry are low, but recent advances in clinical trial design, proof-of- concept, and pre-clinical decision making are set to reduce the attrition rate. Researchers and executives at the inaugural Phase III Clinical Trials conference will be meeting to discuss the latest in regulatory, trial design, phase II to III confidence, success and failure case studies.
 
 
Organized by: Cambridge Healthtech Institute
Invited Speakers: Life sciences, pharmaceutical, informatics and IT professionals
 
Deadline for Abstracts: 2012-03-06
 
Registration: Online
E-mail: rblack@healthtech.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.